Myocardial Uptake of Ga-68-Pentixafor in a Patient With Systemic Amyloidosis

Qingqing Pan,Yaping Luo,Xinxin Cao,Jian Li
DOI: https://doi.org/10.1097/RLU.0000000000004406
IF: 10.6
2022-01-01
Clinical Nuclear Medicine
Abstract:A 55-year-old man presented with chest tightness and lower-limb edema for 1 year. Laboratory and imaging examinations suggested cardiac amyloidosis. Both F-18-FDG and Ga-68-pentixafor PET/CT showed increased uptake in the myocardium of the left ventricle, whereas the bone marrow had diffusely mild uptake of Ga-68-pentixafor without bone destruction. Tc-99m-MDP bone scintigraphy also detected extraosseous uptake in the heart, gut, kidneys, and soft tissue. The biopsy of the abdominal subcutaneous fat confirmed amyloid deposits, and the patient was finally diagnosed with primary systemic amyloidosis. This case demonstrated that cardiac amyloidosis might show increased Ga-68-pentixafor uptake in myocardium.
What problem does this paper attempt to address?